ArticleCancer cell international2025

Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer.

Hongmei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.